AMR and Cancer - Deep Dive into the Mechanisms

Antimicrobial resistance (AMR) is an increasingly important challenge in cancer care, influencing infection risk, treatment delivery, patient outcomes, and supportive care strategies across the oncology pathway. This three-part webinar series is designed for scientists and researchers with an interest in AMR who want to better understand the clinical realities, emerging evidence, and future challenges at the intersection of infection and cancer.

Bringing together experts in oncology, infectious diseases, immunology, and antimicrobial stewardship, the series will explore why cancer patients are uniquely vulnerable to resistant infections, how antimicrobials influence treatment outcomes, and what future models of stewardship could look like in oncology and palliative care settings.

The series is chaired by Prof Anna Olsson Brown and kindly supported by an education grant from bioMérieux. 

As part of the Microbiology Society's Knocking out AMR project, the Society presents 'Deep Dive into the Mechanisms'. 
For this webinar, we have our chair Prof Anna Olsson-Brown and speakers for this event are to be announced.

Why are cancer patients particularly susceptible to resistant infections? This session explores the biological and clinical mechanisms underpinning infection risk in oncology populations, including immune dysfunction, inflammation, treatment-associated vulnerabilities, and host–pathogen interactions. Attendees will gain insight into the complex interplay between cancer, immunity, infection, and antimicrobial resistance.